Chunxiao Xu

Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors

Yong Jia, Cai‐Hong Yun, Eunyoung Park et al. · Nature · 2016 · 879 citations · Full text

Medicine, Oncology, Pharmacology +11

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

Yan Lan, Dong Zhang, Chunxiao Xu et al. · Science Translational Medicine · 2018 · 488 citations

Life Sciences, Immunology, Oncology +17

Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

Peter S. Hammerman, Martin L. Sos, Alex H. Ramos et al. · Cancer Discovery · 2011 · 472 citations · Full text

Medicine, Genetics, Oncology +16

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Chen Zhao, Katherine A. Cheng, Zandra E. Walton et al. · Nature · 2012 · 451 citations

Medicine, Genetics, Oncology +10

Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression

Chunxiao Xu, Christine M. Fillmore, Shohei Koyama et al. · Cancer Cell · 2014 · 392 citations · Full text

Medicine, Oncology, Pathology +15